pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,361 catalysts · 5,063 phase readout · 2,308 8k filing · 298 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa298
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06420531: Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Prematurity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04946253: SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05175053: Early RRT in AKI After Cardiac Surgery

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512245: Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Acellular Dermal Matrix, Alveolar Mucosa

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02583672: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

    Sponsor: University of Minnesota. Phase: PHASE2. Conditions: Gaucher Disease Type 1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04804072: INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

    Sponsor: HIV Prevention Trials Network. Phase: NA. Conditions: HIV Infections, Drug Use, Opioid Use, Opioid-use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01617395: Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04950439: Pyrophosphate and Arterial Calcification in Chronic Kidney Disease

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Chronic Kidney Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07327177: BFR Rope Training in Male Volleyball Players

    Sponsor: Karabuk University. Phase: NA. Conditions: Volleyball, Performance, Power

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07050875: Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

    Sponsor: ABLE Human Motion S.L.. Phase: NA. Conditions: Acquired Brain Injury (Including Stroke)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07346157: Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

    Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05134857: The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

    Sponsor: Washington State University. Phase: PHASE2. Conditions: Alcohol Use Disorder (AUD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03972657: A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06434012: Barts Endocarditis Research Registry

    Sponsor: Queen Mary University of London. Phase: . Conditions: Infective Endocarditis, Endocarditis, Endocarditis, Bacterial

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07020312: Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery

    Sponsor: Rush University Medical Center. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction, Total Hip Arthroplasty (THA), Total Knee Arthroplasty, Hip Arthroscopy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07325630: Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer

    Sponsor: Zhejiang Cancer Hospital. Phase: PHASE2. Conditions: IBI363 + Chemotherapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001230: Host Response to Infection and Treatment in Filarial Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Filariasis, Helminthiasis, Parasitic Infection, Mansonelliasis, Onchocerciasis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06883630: A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

    Sponsor: RemeGen Co., Ltd.. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05865028: A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

    Sponsor: Elizabeth J Franzmann. Phase: PHASE2. Conditions: Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06439628: ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

    Sponsor: Chinese PLA General Hospital. Phase: . Conditions: Migraine

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06282328: HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting

    Sponsor: Castagna Antonella. Phase: . Conditions: Hiv, HIV Infections, AIDS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07398365: Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

    Sponsor: University of Edinburgh. Phase: . Conditions: Bipolar Affective Disorder, Schizophrenia Disorders, Depression Disorders, Personality Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321067: Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

    Sponsor: Ahmed Karam Helmy. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02868268: Neuroblastoma Precision Trial

    Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06766968: Prolonged Compression Following Foam Sclerotherapy

    Sponsor: Pirogov Russian National Research Medical University. Phase: NA. Conditions: Chronic Venous Disorder, Varicose Veins Leg

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07562568: SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06720740: The RELIEF™ Ureteral Stent Randomized Controlled Trial

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Kidney Stone

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05919940: Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )

    Sponsor: Technical University of Munich. Phase: NA. Conditions: ICU Acquired Weakness, Muscle Atrophy, Energy Malnutrition Protein, Quality of Life, Morphological and Microscopic Findings, Metabolic Disturbance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07166289: Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

    Sponsor: Laureate Institute for Brain Research, Inc.. Phase: NA. Conditions: Treatment-Resistant Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07343440: Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study

    Sponsor: HEIDEGGER CP. Phase: NA. Conditions: Critical Illness, ICU

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07024589: First-in-Human Trial of Oral AN2-502998

    Sponsor: AN2 Therapeutics, Inc. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05047250: A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

    Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07687550: Alterations in Spiking Following Muscle Fatigue in Volleyball Players

    Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Fatigue

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05204550: Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

    Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: COVID-19

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07517991: Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy

    Sponsor: Ataturk University. Phase: NA. Conditions: Periodontitis, Periodontitis Stage I, Periodontitis Stage II

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03958591: Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification

    Sponsor: Yanbing Li. Phase: PHASE4. Conditions: Diabetes type2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06529718: Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

    Sponsor: UNICANCER. Phase: PHASE2. Conditions: Biliary Tract Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05051618: Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Multiple Sclerosis, Major Depressive Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06391918: Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

    Sponsor: GenVivo, Inc.. Phase: PHASE1. Conditions: Solid Tumor, Adult

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07467720: Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Radiation Protection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07378124: LLL vs. SDL for LBBP: A Non-inferiority RCT

    Sponsor: Ningbo No.2 Hospital. Phase: NA. Conditions: Bradycardia, Conduction Block, Atrioventricular

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07415382: Frailty, Dual-Task Performance, and Activities of Daily Living in Older Adults

    Sponsor: KTO Karatay University. Phase: . Conditions: Older Adults (60 - 85 Years Old)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06147024: Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

    Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Aortic Aneurysm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06965959: Effects of Exergaming and Autogenic Relaxation on Psychological Well-Being in Nursing Home Residents

    Sponsor: Cumhuriyet University. Phase: NA. Conditions: Psychological Well-being, Nursing Homes Residents, Aging, Exergaming, Mind-Body Therapies, Quality of Life, Health Promotion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06915116: Acupuncture for People Experiencing Period Loss Due to Chemotherapy

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Cancer, Period Problem

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02041416: Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

    Sponsor: City of Hope Medical Center. Phase: . Conditions: Cancer, Solid Tumor, Hematologic Malignancy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282406: Pupil-Indexed Noninvasive Neuromodulation

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Paresis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04356287: Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

    Sponsor: Marie Hudson, MD. Phase: PHASE1. Conditions: Sclerosis, Systemic, Mesenchymal Stem Cells

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07640516: The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Ultrasound Guided Peripheral Nerve Blocks as a Solo Anesthetic Technique in High Risk Patients Undergoing Unilateral Above Knee Amputation .

    Sponsor: Kasr El Aini Hospital. Phase: NA. Conditions: Analgesia Assessment, Above Knee Amputation, Fentanyl vs Dexmedetomidine

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07095504: A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Cardiovascular Health

    full page →ctgov ↗
    ← prev
    page 94 of 108
    next →